These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 12829926

  • 1. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
    Nakai K, Mineishi S, Kami M, Saito T, Hori A, Kojima R, Imataki O, Hamaki T, Yoshihara S, Ohnishi M, Kim SW, Ando T, Fumitoh A, Kanda Y, Makimoto A, Tanosaki R, Kanai S, Heike Y, Ohnishi T, Kawano Y, Wakasugi H, Takaue Y.
    Transplantation; 2003 Jun 27; 75(12):2135-43. PubMed ID: 12829926
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
    Saito T, Kanda Y, Kami M, Kato K, Shoji N, Kanai S, Ohnishi T, Kawano Y, Nakai K, Ogasawara T, Matsubara H, Makimoto A, Tanosaki R, Tobinai K, Wakasugi H, Takaue Y, Mineishi S.
    Clin Cancer Res; 2002 Apr 27; 8(4):1014-20. PubMed ID: 11948108
    [Abstract] [Full Text] [Related]

  • 3. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 27; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 4. Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.
    Schetelig J, Bornhäuser M, Kiehl M, Schwerdtfeger R, Kröger N, Runde V, Zabelina T, Held TK, Thiede C, Fauser AA, Beelen D, Zander A, Ehninger G, Siegert W, Cooperative German Transplant Study Group.
    Bone Marrow Transplant; 2004 Mar 27; 33(5):483-90. PubMed ID: 14716342
    [Abstract] [Full Text] [Related]

  • 5. Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.
    Hamaki T, Kami M, Kim SW, Onishi Y, Kishi Y, Murashige N, Hori A, Kojima R, Sakiyama M, Imataki O, Heike Y, Tanosaki R, Masuo S, Miyakoshi S, Taniguchi S, Tobinai K, Takaue Y.
    Bone Marrow Transplant; 2004 May 27; 33(9):891-900. PubMed ID: 15048142
    [Abstract] [Full Text] [Related]

  • 6. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
    Chan GW, Gorgun G, Miller KB, Foss FM.
    Biol Blood Marrow Transplant; 2003 Mar 27; 9(3):170-6. PubMed ID: 12652467
    [Abstract] [Full Text] [Related]

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 27; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 8. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 27; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 9. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct 27; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 10. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
    Murashige N, Kami M, Mori S, Katayama Y, Kobayashi K, Onishi Y, Hori A, Kishi Y, Hamaki T, Tajima K, Kanda Y, Tanosaki R, Takaue Y.
    Am J Hematol; 2008 Aug 27; 83(8):630-4. PubMed ID: 18454459
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec 27; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 12. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
    Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C, Quinlan D, Stewart D.
    Biol Blood Marrow Transplant; 2007 Mar 27; 13(3):299-306. PubMed ID: 17317583
    [Abstract] [Full Text] [Related]

  • 13. Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality.
    Hartwig UF, Winkelmann N, Wehler T, Kreiter S, Schneider PM, Meyer RG, Ullmann AJ, Huber C, Kolbe K, Herr W.
    Ann Hematol; 2005 May 27; 84(5):331-8. PubMed ID: 15726363
    [Abstract] [Full Text] [Related]

  • 14. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
    Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Masmas TN, Dickmeiss E, Heilmann C, Vindeløv LL.
    Biol Blood Marrow Transplant; 2004 May 27; 10(5):337-46. PubMed ID: 15111933
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
    Nakagawa T, Kami M, Hori A, Kim SW, Murashige N, Hamaki T, Kishi Y, Fujimoto H, Matsuoka N, Okajima E, Komiyama M, Tobisu K, Wakayama T, Uike N, Tajima K, Makimoto A, Mori S, Tanosaki R, Takaue Y, Kakizoe T.
    Exp Hematol; 2004 Jul 27; 32(7):599-606. PubMed ID: 15246155
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome.
    Tanosaki R, Uike N, Utsunomiya A, Saburi Y, Masuda M, Tomonaga M, Eto T, Hidaka M, Harada M, Choi I, Yamanaka T, Kannagi M, Matsuoka M, Okamura J.
    Biol Blood Marrow Transplant; 2008 Jun 27; 14(6):702-8. PubMed ID: 18489996
    [Abstract] [Full Text] [Related]

  • 17. Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation.
    Saito T, Kanda Y, Nakai K, Kim SW, Arima F, Kami M, Tanosaki R, Tobinai K, Wakasugi H, Heike Y, Mineishi S, Takaue Y.
    Bone Marrow Transplant; 2003 Sep 27; 32(6):601-8. PubMed ID: 12953133
    [Abstract] [Full Text] [Related]

  • 18. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
    Kröger N, Zabelina T, Binder T, Ayuk F, Bacher U, Amtsfeld G, Lellek H, Schrum J, Erttmann R, Eiermann T, Zander A.
    Biol Blood Marrow Transplant; 2009 Apr 27; 15(4):454-62. PubMed ID: 19285633
    [Abstract] [Full Text] [Related]

  • 19. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
    Graf Finckenstein F, Zabelina T, Dürken M, Dahlke J, Kröger N, Krüger W, Janka-Schaub G, Erttmann R, Zander AR, Kabisch H.
    Klin Padiatr; 2002 Apr 27; 214(4):206-11. PubMed ID: 12165903
    [Abstract] [Full Text] [Related]

  • 20. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander AR.
    Exp Hematol; 2008 Aug 27; 36(8):1047-54. PubMed ID: 18456390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.